The Searle Company Limited (PSX:SEARL)

Market Cap	68.25B +22.3%
Revenue (ttm)	30.67B +8.3%
Net Income	-903.39M
EPS	-1.54
Shares Out	588.22M
PE Ratio	48.16
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	2,025,116
Average Volume	3,474,527
Open	116.00
Previous Close	116.55
Day's Range	114.50 - 117.70
52-Week Range	52.75 - 137.44
Beta	0.52
RSI	38.19
Earnings Date	Feb 27, 2026

About The Searle Company

The Searle Company Limited, together with its subsidiaries, manufactures and sells pharmaceutical and other consumer products in Pakistan, Sri Lanka, Myanmar, Cambodia, Vietnam, Iraq, Oman, Afghanistan, Tajikistan, Laos, Kenya, and internationally. The company offers pharmaceutical products, such as analgesics and muscle relaxants, anti-allergy and anti-tussive, anti-anemic, anti-chelating, anti-infective, anti-neoplastic, anti-thrombotic, cardiovascular, endocrinology and metabolism, gastrointestinal, gynecology, urology and sex hormones, hepa...

• Industry: Pharmaceuticals
• Sector: Healthcare
• Founded: 1965
• Employees: 3,799
• Stock Exchange: Pakistan Stock Exchange
• Ticker Symbol: SEARL

Financial Performance

In fiscal year 2025, The Searle Company's revenue was 28.60 billion, a decrease of -2.72% compared to the previous year's 29.40 billion. Losses were -1.40 billion, -41.15% less than in 2024.